Infused CD34+ cell dose predicts long-term survival in acute myelogenous leukemia patients who received allogeneic bone marrow transplantation from matched sibling donors in first complete remission. (Q53627317)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Infused CD34+ cell dose predicts long-term survival in acute myelogenous leukemia patients who received allogeneic bone marrow transplantation from matched sibling donors in first complete remission. |
scientific article |
Statements
Infused CD34+ cell dose predicts long-term survival in acute myelogenous leukemia patients who received allogeneic bone marrow transplantation from matched sibling donors in first complete remission (English)
Se-Hoon Lee
Mark H Lee
Je-Hwan Lee
Kyoo-Hyung Lee
Jeeyun Lee
Keon Woo Park
Jung Hun Kang
Kihyun Kim
Won Seog Kim
Chul Won Jung
Seong-Jun Choi
Jung-Hee Lee
Keunchil Park
1 February 2005